David J. Kurz

3.5k total citations · 1 hit paper
52 papers, 2.5k citations indexed

About

David J. Kurz is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David J. Kurz has authored 52 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David J. Kurz's work include Acute Myocardial Infarction Research (19 papers), Coronary Interventions and Diagnostics (15 papers) and Telomeres, Telomerase, and Senescence (10 papers). David J. Kurz is often cited by papers focused on Acute Myocardial Infarction Research (19 papers), Coronary Interventions and Diagnostics (15 papers) and Telomeres, Telomerase, and Senescence (10 papers). David J. Kurz collaborates with scholars based in Switzerland, United Kingdom and Canada. David J. Kurz's co-authors include Jorge D. Erusalimsky, Ying Hong, Stéphanie Decary, Alexander Akhmedov, Elisabeth Trivier, Franz R. Eberli, Osmund Bertel, Steve Barker, Thomas F. Lüscher and Barbara Naegeli and has published in prestigious journals such as The Lancet, Genes & Development and PLoS ONE.

In The Last Decade

David J. Kurz

52 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells

2000 688 citations David J. Kurz, Ying Hong et al. profile →

Peers

Countries citing papers authored by David J. Kurz

Since Specialization

Citations

This map shows the geographic impact of David J. Kurz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Kurz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Kurz more than expected).

Fields of papers citing papers by David J. Kurz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Kurz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Kurz. The network helps show where David J. Kurz may publish in the future.

Co-authorship network of co-authors of David J. Kurz

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Kurz. A scholar is included among the top collaborators of David J. Kurz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Kurz. David J. Kurz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Complex primary percutaneous coronary intervention with ultrathin‐strut biodegradable versus thin‐strut durable polymer drug‐eluting stents in patients with ST‐segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized trial 2023 ·Catheterization and Cardiovascular Interventions ·Juan F. Iglesias, Olivier Müller, Sylvain Losdat, Marco Roffi, David J. Kurz, Daniel Weilenmann, Christoph Kaiser, Dik Heg, Stephan Windecker, Thomas Pilgrim	1
2	Multivessel percutaneous coronary intervention with thin-strut biodegradable versus durable polymer drug-eluting stents in ST-segment elevation myocardial infarction: A subgroup analysis of the BIOSTEMI randomized trial 2021 ·International Journal of Cardiology ·Juan F. Iglesias, Olivier Müller, Sylvain Losdat, Marco Roffi, David J. Kurz, Daniel Weilenmann, Christoph Kaiser, Dik Heg, Marco Valgimigli, Stephan Windecker, Thomas Pilgrim	2
3	Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMI 2021 ·JACC: Cardiovascular Interventions ·Thomas Pilgrim, Olivier Müller, Dik Heg, Marco Roffi, David J. Kurz, Igal Moarof, Daniel Weilenmann, Christoph Kaiser, Maxime Tapponnier, Sylvain Losdat, Éric Eeckhout, Marco Valgimigli, Peter Jüni, Stephan Windecker, Juan F. Iglesias	30
4	Efficacy and Safety of Abbreviated Eptifibatide Treatment in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention 2020 ·The American Journal of Cardiology ·(unknown), (unknown), David J. Kurz, Franz R. Eberli, Oliver Senn, Rainer Zbinden, Ulrike Held, Matthias R. Meyer	5
5	Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II 2019 ·PLoS ONE ·Raban Jeger, Matthias Pfisterer, D. Vogt, Søren Galatius, Ulrik Abildgaard, Christoph Naber, Hannes Alber, Franz R. Eberli, David J. Kurz, Giovanni Pedrazzini, André Vuilliomenet, Daniel Weilenmann, Hans Rickli, Kim Wadt Hansen, Peter Rickenbacher, David Conen, Christian Müller, Stefan Osswald, Nicole Gilgen, Christoph Kaiser	3
6	Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 2018 ·Frontiers in Cardiovascular Medicine ·Cróchán J. O’Sullivan, (unknown), Rainer Zbinden, David J. Kurz, Alain Bernheim, Aaron Liew, Matthias R. Meyer, David Tüller, Franz R. Eberli	10
7	Efficacy and safety of transcatheter closure in adults with large or small atrial septal defects 2016 ·SpringerPlus ·Matthias R. Meyer, David J. Kurz, Alain Bernheim, Oliver Kretschmar, Franz R. Eberli	8
8	Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy 2015 ·Urology ·Serge Ginzburg, Robert G. Uzzo, J.T. Walton, Christopher Miller, David J. Kurz, Tianyu Li, (unknown), Ronak A. Gor, Anthony Corcoran, Rosalia Viterbo, David Y.T. Chen, Richard E. Greenberg, Marc C. Smaldone, Alexander Kutikov	55
9	Medical therapy of coronary artery disease after percutaneous intervention 2013 ·Current Opinion in Pharmacology ·David J. Kurz, Franz R. Eberli	9
10	Intravenous enoxaparin versus unfractionated heparin in unselected patients undergoing percutaneous coronary interventions: the Zurich enoxaparin versus unfractionated heparin in PCI study (ZEUS) 2010 ·EuroIntervention ·Osmund Bertel, David Ramsay, (unknown), David J. Kurz, (unknown), Edwin Straumann, J. Frielingsdorf, Dominik Maurer, Barbara Naegeli	2
11	Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing 2007 ·EP Europace ·Barbara Naegeli, David J. Kurz, Daniel Koller, Edwin Straumann, Markus Furrer, Dominik Maurer, Elisabeth I. Minder, Osmund Bertel	14
12	Degenerative Aortic Valve Stenosis, but not Coronary Disease, Is Associated With Shorter Telomere Length in the Elderly 2006 ·Arteriosclerosis Thrombosis and Vascular Biology ·David J. Kurz, Barbara Kloeckener‐Gruissem, Alexander Akhmedov, Franz R. Eberli, Ines Bühler, Wolfgang Berger, Osmund Bertel, Thomas F. Lüscher	18
13	Cellular senescence in vivo: Its relevance in ageing and cardiovascular disease 2005 ·Experimental Gerontology ·Jorge D. Erusalimsky, David J. Kurz	191
14	Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention 2005 ·American Heart Journal ·Edwin Straumann, David J. Kurz, Jörg Muntwyler, (unknown), (unknown), Barbara Naegeli, Jürgen Frielingsdorf, Ernst Schuiki, (unknown), Osmund Bertel, Giatgen A. Spinas	48
15	Distinct functions of junD in cardiac hypertrophy and heart failure 2005 ·Genes & Development ·Roméo Ricci, Urs Eriksson, Gavin Y. Oudit, Robert Eferl, Alexander Akhmedov, Izabela Sumara, Grzegorz Sumara, Zamaneh Kassiri, Jean-Pierre David, Latifa Bakiri, (unknown), (unknown), Martina Rath, David J. Kurz, (unknown), Jean‐Claude Perriard, Peter H. Backx, Josef Penninger, Erwin F. Wagner	39
16	Aberrant tendinous chords with tethering of the tricuspid leaflets: a congenital anomaly causing severe tricuspid regurgitation 2004 ·Heart ·Richard Kobza, David J. Kurz, Erwin Oechslin, René Prêtre, Michel Züber, Paul Vogt, Rolf Jenni	17
17	Differential Regulation of Telomerase in Endothelial Cells by Fibroblast Growth Factor‐2 and Vascular Endothelial Growth Factor‐A: Association with Replicative Life Span 2004 ·Annals of the New York Academy of Sciences ·Elisabeth Trivier, David J. Kurz, Ying Hong, (unknown), Jorge D. Erusalimsky	27
18	Delayed Femoral Vein Thrombosis after Ultrasound-guided Thrombin Injection of a Postcatheterization Pseudoaneurysm 2003 ·Journal of Vascular and Interventional Radiology ·David J. Kurz, Karl-Peter Jungius, Thomas F. Lüscher	11
19	Early atherogenesis in senescence-accelerated mice 2003 ·Experimental Gerontology ·(unknown), (unknown), Ying Hong, Emma Hawe, David J. Kurz, Jorge D. Erusalimsky	29
20	A double-blind, randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stenting 2000 ·American Heart Journal ·Benedict R. Lucchesi, David J. Kurz, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact